A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
200
Participants
Timeline
Start Date
November 30, 1984
Study Completion Date
September 30, 2000
Conditions
Breast NeoplasmsNeoplasm Metastasis
Interventions
PROCEDURE
high dose melphalan and autologous bone marrow transplantation
Trial Locations (1)
20892
National Cancer Institute (NCI), Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00001193 - A Multimodality Treatment Approach to Patients With Inflammatory Cancer of the Breast and Locally Advanced Non-Inflammatory Stage III Breast Cancer and Stage IV Breast Cancer | Biotech Hunter | Biotech Hunter